Exagen inc. to participate in upcoming march conferences

San diego, feb. 27, 2023 (globe newswire) -- exagen inc. (nasdaq: xgn), a leading provider of autoimmune testing solutions, today announced that management will participate in the following march investor conferences.

XGN Ratings Summary

XGN Quant Ranking